Dewey Steadman
Stock Analyst
(n/a)
# 4,425
Out of 4,433 analysts
25
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Buy | n/a | $63.77 | - | 5 | Nov 12, 2018 | |
| PCRX Pacira BioSciences | Maintains: Hold | n/a | $31.51 | - | 10 | Oct 2, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Hold | n/a | $6.75 | - | 1 | Aug 14, 2018 | |
| ACET Adicet Bio | Downgrades: Sell | n/a | $1.57 | - | 4 | Apr 19, 2018 | |
| LPCN Lipocine | Downgrades: Hold | n/a | $5.75 | - | 1 | Jan 11, 2018 | |
| SVRA Savara | Maintains: Buy | n/a | $4.72 | - | 2 | Oct 30, 2017 | |
| PRGO Perrigo Company | Maintains: Buy | n/a | $30.10 | - | 2 | Sep 13, 2017 |
ANI Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: n/a
Current: $63.77
Upside: -
Pacira BioSciences
Oct 2, 2018
Maintains: Hold
Price Target: n/a
Current: $31.51
Upside: -
Amneal Pharmaceuticals
Aug 14, 2018
Maintains: Hold
Price Target: n/a
Current: $6.75
Upside: -
Adicet Bio
Apr 19, 2018
Downgrades: Sell
Price Target: n/a
Current: $1.57
Upside: -
Lipocine
Jan 11, 2018
Downgrades: Hold
Price Target: n/a
Current: $5.75
Upside: -
Savara
Oct 30, 2017
Maintains: Buy
Price Target: n/a
Current: $4.72
Upside: -
Perrigo Company
Sep 13, 2017
Maintains: Buy
Price Target: n/a
Current: $30.10
Upside: -